TPOXX

tecovirimat monohydrate · SIGA Technologies, Inc.

Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for TPOXX, covering 2018-07-13 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS [Phase 2]

See pricing